NASDAQ:XERS

Xeris Pharmaceuticals Stock Predictions

etoro logo Buy XERS
*Your capital is at risk
$5.89
-0.110 (-1.83%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

XERS Prediction Chart

XERS Predictions History

Latest community submissions for XERS.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 7, 2025 $4.08 -1.32% $4.24 X 96.12% 0
Mar 7, 2025 $6.00 +45.28% $4.24 V 58.49% 1
Oct 21, 2024 $3.01 -1.68% $3.03 V 99.29% 4
Oct 21, 2024 $3.03 -1.05% $3.03 V 99.93% 10
Oct 21, 2024 Bullish $3.03 X 0
Feb 15, 2024 $3.17 -1.34% $3.21 X 98.66% 1
Feb 15, 2024 $3.14 -2.15% $3.21 X 97.85% 0
Feb 15, 2024 Bullish $3.21 V 0
Feb 15, 2024 Bullish $3.21 V 0
RKP RKP Senior
Feb 6, 2024 $2.51 +1.62% $2.64 V 95.08% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for XERS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT XERIS PHARMACEUTICALS INC
Xeris Pharmaceuticals
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhi...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE